SCHEMBL24240198

SCHEMBL24240198

O=c1ccc(-c2cnccn2)n[nH]1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 2/20 0.47
▸ PDE3B Q13370 3/20 0.45
▸ PDE3A Q14432 3/20 0.45
▸ LMNA P02545 2/20 0.44
▸ KMT2A Q03164 2/20 0.44
▸ MEN1 O00255 1/20 0.44
▸ HDAC3 O15379 1/20 0.42
▸ HDAC4 P56524 1/20 0.42
▸ HDAC1 Q13547 1/20 0.42
▸ HDAC7 Q8WUI4 1/20 0.42
▸ HDAC2 Q92769 1/20 0.42
▸ HDAC10 Q969S8 1/20 0.42
▸ HDAC11 Q96DB2 1/20 0.42
▸ HDAC8 Q9BY41 1/20 0.42
▸ HDAC6 Q9UBN7 1/20 0.42
▸ HDAC9 Q9UKV0 1/20 0.42
▸ HDAC5 Q9UQL6 1/20 0.42
▸ PIM1 P11309 3/20 0.41
▸ PDE4A P27815 1/20 0.38
▸ PDE4B Q07343 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1456606 0.79 CYP1A2 (0.67) CYP1A2PDE3BPDE3ALMNAKMT2A
SCHEMBL31096516 0.76 CYP1A2 (0.58) CYP1A2PDE3BPDE3ALMNAKMT2A
SCHEMBL31096513 0.76 CYP1A2 (0.58) CYP1A2PDE3BPDE3ALMNAKMT2A
SCHEMBL1456234 0.76 CYP1A2 (0.58) CYP1A2PDE3BPDE3ALMNAKMT2A
SCHEMBL11156334 0.74 CYP1A2 (0.67) CYP1A2PDE3BPDE3ALMNAKMT2A
SCHEMBL29454745 0.72 NISCH (0.50) CYP1A2PIM1KDM4EP2RX7ALDH1A1
SCHEMBL29598957 0.72 NISCH (0.50) CYP1A2PIM1KDM4EP2RX7ALDH1A1
SCHEMBL78566 0.72 NISCH (0.50) CYP1A2PIM1KDM4EP2RX7ALDH1A1
SCHEMBL1751891 0.71 CYP1A2 (0.68) CYP1A2PDE3BPDE3ALMNAKMT2A
SCHEMBL904383 0.71 PIM1 (0.41) HDAC3HDAC4HDAC1HDAC7HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4192823-B9 DIFLUOROMETHYL-PYRIDIN-2-YL TRIAZOLES SANIONA AS (DK) 2026-03-18 — — EP disclosed
EP-4192823-B1 DIFLUOROMETHYL-PYRIDIN-2-YL TRIAZOLES SANIONA AS (DK) 2025-12-17 — — EP disclosed
EP-4596558-A2 DIFLUOROMETHYL-PYRIDIN-2-YL TRIAZOLES Boehringer Ingelheim International GmbH (DE) 2025-08-06 — — EP disclosed
EP-4596559-A2 DIFLUOROMETHYL-PYRIDIN-2-YL TRIAZOLES Boehringer Ingelheim International GmbH (DE) 2025-08-06 — — EP disclosed
CN-116888115-A Difluoromethyl-pyridin-2-yl triazoles 勃林格殷格翰国际有限公司 2023-10-13 — — CN disclosed
US-20230286946-A1 DIFLUOROMETHYL-PYRIDIN-2-YL TRIAZOLES BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2023-09-14 — — US disclosed
US-20230286946-A1 DIFLUOROMETHYL-PYRIDIN-2-YL TRIAZOLES BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2023-09-14 — — US disclosed
EP-4192823-A1 DIFLUOROMETHYL-PYRIDIN-2-YL TRIAZOLES Boehringer Ingelheim International GmbH (DE) 2023-06-14 — — EP disclosed
EP-3992188-A1 DIFLUOROMETHYL-PYRIDIN-2-YL TRIAZOLES Boehringer Ingelheim International GmbH (DE) 2022-05-04 — — EP disclosed
EP-3992188-A1 DIFLUOROMETHYL-PYRIDIN-2-YL TRIAZOLES Boehringer Ingelheim International GmbH (DE) 2022-05-04 — — EP disclosed
EP-3971179-A1 DIFLUOROMETHYL-PYRIDIN-2-YL TRIAZOLES Boehringer Ingelheim International GmbH (DE) 2022-03-23 — — EP disclosed
EP-3950683-A1 DIFLUOROMETHYL-PYRIDIN-2-YL TRIAZOLES Boehringer Ingelheim International GmbH (DE) 2022-02-09 — — EP disclosed
EP-3950683-A1 DIFLUOROMETHYL-PYRIDIN-2-YL TRIAZOLES Boehringer Ingelheim International GmbH (DE) 2022-02-09 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230286946-A1 DIFLUOROMETHYL-PYRIDIN-2-YL TRIAZOLES GABRA5, GABRA3, GABRA2 CYP1A2 150/4885PDE3B 475/4885PDE3A 497/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback